Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02768844 · ClinicalTrials.gov registry record · NA
Physiology and Therapeutic Management of Neonatal Abstinence Syndrome
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT02768844 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 46 participants.
The verdict
NCT02768844, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The overall purpose of this project is to to quantify the physiology of neonatal drug withdrawal and develop non-pharmacological techniques to help improve the therapeutic management of Neonatal Abstinence Syndrome (NAS).
Interventions
- OTHER Control
- DEVICE Stochastic Vibrotactile Stimulation (SVS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2011-04 |
| Est. Completion | 2019-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02768844
The ClinicalTrials.gov registry entry for NCT02768844 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02768844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02768844 about?
NCT02768844 is a clinical study titled "Physiology and Therapeutic Management of Neonatal Abstinence Syndrome". The overall purpose of this project is to to quantify the physiology of neonatal drug withdrawal and develop non-pharmacological techniques to help improve the therapeutic management of Neonatal Abstinence Syndrome (NAS).
What is the current status of trial NCT02768844?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2011-04. Estimated completion is 2019-12-15.
What interventions are being tested in trial NCT02768844?
The interventions under investigation include: Control (OTHER), Stochastic Vibrotactile Stimulation (SVS) (DEVICE).
Who is sponsoring clinical trial NCT02768844?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.